Abby Doering in Waterloo, Iowa

Home Iowa Waterloo

Abby Doering has Nurse Practitioner as her primary medical specialty. Their primary office is: 1825 Logan Ave in Waterloo, Iowa.

They're a part of the: Allen Memorial Hospital Corporation medical group which has around 98 members. You can call their office at 319-235-3913 to schedule an appointment. , license information, procedures and more. They attended Sorry, her university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Abby J Doering Office Phone and Directions

Abby Doering
Allen Memorial Hospital Corporation
1825 Logan Ave
Waterloo, Iowa 50703
319-235-3913

Patient Ratings
Please rate your experience with Abby Doering below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 319-235-3913

Enter a starting address:

Healthcare Info for Abby Doering

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Abby Doering is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 5496170847
NPI #: 1962025767
NPI Created On: 05/27/2020
NPI Last Updated Listed as: 11/22/2022
Primary Taxonomy Code: 363LP0808X
License Number:
G158857
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Subsequent hospital inpatient care, typically 25 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $68

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788862887

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: SPRAVATO

Open Associated Drug #1: 50458-028-02